JP2024534786A5 - - Google Patents

Info

Publication number
JP2024534786A5
JP2024534786A5 JP2024509092A JP2024509092A JP2024534786A5 JP 2024534786 A5 JP2024534786 A5 JP 2024534786A5 JP 2024509092 A JP2024509092 A JP 2024509092A JP 2024509092 A JP2024509092 A JP 2024509092A JP 2024534786 A5 JP2024534786 A5 JP 2024534786A5
Authority
JP
Japan
Prior art keywords
poly
nucleic acid
acid sequence
antigen
pharmaceutically acceptable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024509092A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024534786A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/040317 external-priority patent/WO2023022973A2/en
Publication of JP2024534786A publication Critical patent/JP2024534786A/ja
Publication of JP2024534786A5 publication Critical patent/JP2024534786A5/ja
Pending legal-status Critical Current

Links

JP2024509092A 2021-08-16 2022-08-15 ポリヌクレオチド両親媒性物質を含有する組成物及びその使用方法 Pending JP2024534786A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202163233570P 2021-08-16 2021-08-16
US63/233,570 2021-08-16
US202163286952P 2021-12-07 2021-12-07
US63/286,952 2021-12-07
PCT/US2022/040317 WO2023022973A2 (en) 2021-08-16 2022-08-15 Compositions containing polynucleotide amphiphiles and methods of use thereof

Publications (2)

Publication Number Publication Date
JP2024534786A JP2024534786A (ja) 2024-09-26
JP2024534786A5 true JP2024534786A5 (cg-RX-API-DMAC7.html) 2025-08-13

Family

ID=85240944

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024509092A Pending JP2024534786A (ja) 2021-08-16 2022-08-15 ポリヌクレオチド両親媒性物質を含有する組成物及びその使用方法

Country Status (6)

Country Link
US (1) US20250134992A1 (cg-RX-API-DMAC7.html)
EP (1) EP4388102A4 (cg-RX-API-DMAC7.html)
JP (1) JP2024534786A (cg-RX-API-DMAC7.html)
AU (1) AU2022329730A1 (cg-RX-API-DMAC7.html)
CA (1) CA3228856A1 (cg-RX-API-DMAC7.html)
WO (1) WO2023022973A2 (cg-RX-API-DMAC7.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2026519945A (ja) * 2023-04-26 2026-06-19 エリシオ セラピューティクス, インク. ポリヌクレオチド及びポリペプチド両親媒性物質を含有する組成物並びにその使用方法
AU2024277363A1 (en) * 2023-05-25 2025-12-11 Elicio Therapeutics, Inc. Compositions containing p53 peptide amphiphiles and methods of use thereof
JP2026518784A (ja) * 2023-05-25 2026-06-09 エリシオ セラピューティクス, インク. Brafペプチド両親媒性物質を含有する組成物及びその使用方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004108937A1 (en) * 2003-06-04 2004-12-16 Bioleaders Corporation Cell surface expression vector of sars virus antigen and microorganisms transformed thereby
JP5759678B2 (ja) * 2010-04-14 2015-08-05 国立大学法人埼玉大学 核酸リンカー
US9200314B2 (en) * 2010-07-21 2015-12-01 Takara Bio Inc. Synthetic siRNA detection method
CN112587671A (zh) * 2012-07-18 2021-04-02 博笛生物科技有限公司 癌症的靶向免疫治疗
US10093701B2 (en) * 2012-09-07 2018-10-09 University Of Miami Fusion proteins for promoting an immune response, nucleic acids encoding same, and methods of making and use thereof
AU2014322046B2 (en) * 2013-09-20 2021-02-04 Daiichi Sankyo Company, Limited Complex containing oligonucleotide having immunopotentiating activity and use thereof
EP3247328B1 (en) * 2015-01-21 2026-01-07 Genevant Sciences Gmbh Methods, compositions, and systems for delivering therapeutic and diagnostic agents into cells
US12247052B2 (en) * 2018-03-02 2025-03-11 Elicio Therapeutics, Inc. CpG amphiphiles and uses thereof
EP3801612A1 (en) * 2018-05-29 2021-04-14 The Provost, Fellows, Foundation Scholars, and the other members of Board, of the College of the Holy & Undiv. Trinity of Queen Elizabeth near Dublin Vaccine adjuvants
JP2022525781A (ja) * 2019-03-20 2022-05-19 マサチューセッツ インスティテュート オブ テクノロジー 免疫細胞療法における両親媒性物質の使用およびそのための組成物

Similar Documents

Publication Publication Date Title
JP7625637B2 (ja) B型肝炎ウイルス感染のためのRNAi薬
JP7763907B2 (ja) B型肝炎ウイルス感染のためのRNAi薬
US7709449B2 (en) Nucleic acid-based compounds and methods of use thereof
CN111527207A (zh) GalNAc衍生物
PT850300E (pt) Metodo de modulacao da expressao de genes com resposta imunoestimulante reduzida
CA2081777A1 (en) Inhibition of influenza virus replication by oligonucleotides
JP2006515277A5 (cg-RX-API-DMAC7.html)
JP2024532465A5 (cg-RX-API-DMAC7.html)
EP3758712B1 (en) Cpg amphiphiles and uses thereof
CN115252772A (zh) 人工合成的含CpG单链脱氧寡核苷酸在疫苗中的应用
BR112015016420B1 (pt) Composto de oligonucleotídeo imunorregulatório, composição farmacêutica e uso do composto iro ou da composição farmacêutica
JP2024533371A5 (cg-RX-API-DMAC7.html)
JP2024529875A5 (cg-RX-API-DMAC7.html)
JP2023548205A5 (cg-RX-API-DMAC7.html)
JP2023528016A5 (cg-RX-API-DMAC7.html)
CN121620390A (zh) 用于调节针对乙型肝炎病毒感染的免疫应答的寡核苷酸
TW202345861A (zh) 經修飾之間隔體寡聚物及其使用方法
CN114127292A (zh) 减轻反义核酸的毒性的方法
US12163132B2 (en) Gapmer antisense oligonucleotides targeting SARS-CoV-2 for treating COVID 19
RU2006111336A (ru) Р185-кодирующая днк и ее терапевтические применения
RU2000121049A (ru) Антигены neisseria meningitidis
WO2024248367A1 (ko) 단백질 고효율 발현용 mRNA 구조체 플랫폼
TW202604544A (zh) 抑制CTGF基因表達的siRNA及其組合物
WO2026026811A1 (zh) 一种具有双靶点基因抑制作用的核酸缀合物及其应用
HK40062579A (en) Rnai agents for hepatitis b virus infection